Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Search results

Bayer Accelerates Growth With siRNA, AI Deals and Pipeline Progress
Bayer Accelerates Growth With siRNA, AI Deals and Pipeline Progress

German pharma giant Bayer AG BAYRY has entered into a collaboration and global licensing agreement with Soufflé Therapeutics to develop a heart-targeted small interfering RNA (siRNA) therapy in a

Bayer Shares Jump as Supreme Court Agrees to Review Key Roundup Case
Bayer Shares Jump as Supreme Court Agrees to Review Key Roundup Case

Shares of Bayer AG BAYRY gained 6.41% on Jan. 19, after the company announced that the Supreme Court agreed to review the Durnell Roundup case.

Bayer acquired Roundup weedkiller through Monsanto’s

Bayer Stock Jumps on Nubeqa Outlook, Presents Pharma Strategy
Bayer Stock Jumps on Nubeqa Outlook, Presents Pharma Strategy

Shares of German pharma giant Bayer AG BAYRY gained 6.6% on Jan. 14, following an update by partner Orion, a Finnish pharmaceutical company.

Orion believes that long-term annual net sales from